Journals / Haseki Tıp Bülteni / 2020 / Cilt: 58 - Sayı: 5

Relationship of Gender and Serum Calcium and/or Phosphorus Levels on Admission with the Etiology and Early Prognosis of Hypercalcemia

Başvuru Anındaki Serum Kalsiyum ve/veya Fosfor Düzeyleri ve Cinsiyetin, Hiperkalseminin Etiyolojisi ve Erken Prognozu ile İlişkisi

Pages
460–464
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Then, the groups were compared statistically in termsof gender, biochemical values and one-week survival.Results: The median level of serum cCa was found to besignificantly higher in males (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Hypercalcemia (HCM) is a common clinical problemcharacterized by a serum corrected calcium (cCa) level of>10.7 mg/dL.
📊
Key Findings & Data:Primary hyperparathyroidism and malignancy aremostly (90%) involved in the etiology.
💡
Conclusion & Impact:Then, the groups were compared statistically in termsof gender, biochemical values and one-week survival.Results: The median level of serum cCa was found to besignificantly higher in males (p
🔬Design:Review & Systematic Survey
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Hypercalcemia (HCM) is a common clinical problemcharacterized by a serum corrected calcium (cCa) level of>10.7 mg/dL. Primary hyperparathyroidism and malignancy aremostly (90%) involved in the etiology. In this study, we aimedto determine the relationship of cCa and phosphorus (P) levels,cCa/P ratio and gender with the etiology of HCM and one-weekmortality.Methods: Records of HCM patients older than 18 years of agewho were hospitalized between January 1, 2017 and December31, 2018 were retrospectively reviewed. Age, gender, cCa and Plevels, HCM etiology and one-week survival status of the patientswere recorded. Subsequently, the patients were divided into twogroups according to whether the etiology of HCM was benign ormalignant. Then, the groups were compared statistically in termsof gender, biochemical values and one-week survival.Results: The median level of serum cCa was found to besignificantly higher in males (p

Özet

Amaç: Hiperkalsemi (HK), serum düzeltilmiş kalsiyum (dCa) seviyesinin 10,7 mg/dL’nin üzerinde olması ile karakterize yaygın bir klinik sorundur. Etiyolojide çoğunlukla (%90) primer hiperparatiroidizm ve malignite yer alır. Biz bu çalışmamızla tanı anındaki kalsiyum ve fosfor düzeyleri, dCa/P oranı ve cinsiyetin, hiperkalsemi etiyolojisi ve 1. hafta mortalitesi ile ilişkisini saptamayı amaçladık. Yöntemler: 1 Ocak 2017 ve 31 Aralık 2018 tarihleri arasında hastanemizde yatarak tetkik ve tedavi edilen 18 yaşından büyük hiperkalsemili hastaların kayıtları retrospektif olarak incelendi. Hastaların yaş, cinsiyet, kalsiyum ve fosfor düzeyleri, HK etiyolojisi ve 1.hafta sağkalım durumları kaydedildi. Hastalar HK etiyolojisinin benign ya da malign nedenlere bağlı olmasına göre iki gruba ayrıldı. Gruplar, yaş, cinsiyet, belirtilen biyokimyasal değerler ve ilk hafta sağkalımı açısından istatistiksel olarak karşılaştırıldı. Bulgular: Serum dCa’nın medyan seviyesi erkeklerde anlamlı olarak daha yüksek tespit edildi (p

🔖

Cite This Article

ERİŞMİŞ, B., YILMAZ, D., KUMBASAR, A., KARANDERE, F., HURŞİTOĞLU, M. (2022). Relationship of Gender and Serum Calcium and/or Phosphorus Levels on Admission with the Etiology and Early Prognosis of Hypercalcemia. Haseki Tıp Bülteni, Cilt: 58 - Sayı: 5, 460–464. https://ajindex.com/articles/535039

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Shane E. Clinical manifestations of hypercalcemia - UpToDate. (cited 2020 Jan 15). Available from: https:// www.uptodate.com/contents/clinical-manifestations-of hypercalcemia?search=hypercalcemia&source=search_ result&selectedTitle=3~150&usage_type=default&display_ rank=3 2. Vakiti A, Mewawalla P. Malignancy-Related Hypercalcemia [Internet]. StatPearls. StatPearls Publishing; 2019 (cited 2020 Jan 15). 3. Catalano A, Chilà D, Bellone F, et al. Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? J Clin Transl Endocrinol 2018;13:9-13. 4. Hamilton F, Carroll R, Hamilton W, Salisbury C. The risk of cancer in primary care patients with hypercalcaemia: a cohort study using electronic records. Br J Cancer 2014;111:1410-2. 5. Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies conducted using observational routinelycollected health Data (RECORD) Statement. PLOS Med 2015;12:e1001885. 6. Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res 1991;6(Suppl 2):S51-9. 7. Minisola S, Pepe J, Piemonte S, Cipriani C. The diagnosis and management of hypercalcaemia. BMJ 2015;350:h2723. 8. Mousseaux C, Dupont A, Rafat C, et al. Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients. Ann Intensive Care 2019;9:133. 9. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 1990;112:499-504.